Ibrutinib therapy is effective in B-cell prolymphocytic leukemia exhibiting MYC aberrations

被引：14
作者：
Damlaj, Moussab [1 ,2 ,3 ]
Al Balwi, Mohammed [2 ,3 ,4 ]
Al Mugairi, Areej M. [4 ]
机构：
[1] King Abdul Aziz Med City, Dept Oncol, Div Hematol & HSCT, POB 22490, Riyadh, Saudi Arabia
[2] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia
[3] King Saud bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia
[4] King Abdul Aziz Med City, Dept Pathol & Lab Med, Riyadh, Saudi Arabia
来源：
LEUKEMIA & LYMPHOMA | 2018年 / 59卷 / 03期
关键词：
CHRONIC LYMPHOCYTIC-LEUKEMIA; ABNORMALITIES;
D O I：
10.1080/10428194.2017.1347653
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：739 / 742
页数：4
相关论文
共 14 条
[1]   Complex karyotype including chromosomal translocation (8;14) (q24;q32) in one case with B-cell prolymphocytic leukemia [J].
Crisostomo, Ricardo H. ;
Fernandez, Jose A. ;
Caceres, William .
LEUKEMIA RESEARCH, 2007, 31 (05) :699-701
[2]   The c-Myc target gene network [J].
Dang, Chi V. ;
O'Donnell, Kathryn A. ;
Zeller, Karen I. ;
Nguyen, Tam ;
Osthus, Rebecca C. ;
Li, Feng .
SEMINARS IN CANCER BIOLOGY, 2006, 16 (04) :253-264
[3]   How I treat prolymphocytic leukemia [J].
Dearden, Claire .
BLOOD, 2012, 120 (03) :538-551
[4]   Aberrations of MYC Are a Common Event in B-Cell Prolymphocytic Leukemia [J].
Flatley, Ellen ;
Chen, Andy I. ;
Zhao, Xiangrong ;
Jaffe, Elaine S. ;
Dunlap, Jennifer B. ;
Pittaluga, Stefania ;
Abdullah, Shahed ;
Olson, Susan B. ;
Spurgeon, Stephen E. ;
Fan, Guang .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 142 (03) :347-354
[5]   Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia [J].
Gordon, Max J. ;
Raess, Philipp W. ;
Young, Kathleen ;
Spurgeon, Stephen E. F. ;
Danilov, Alexey V. .
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 179 (03) :501-503
[6]   B-Cell Prolymphocytic Leukemia Carrying t(8;14)(q24;q32), Associated with Both Autoimmune Hemolytic Anemia and Pure Red Cell Aplasia [J].
Iioka, Futoshi ;
Akasaka, Takashi ;
Hayashida, Masahiko ;
Okumura, Atsuko ;
Ohno, Hitoshi .
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2014, 54 (03) :219-224
[7]   CORRELATION BETWEEN IMMUNOGLOBULIN LIGHT CHAIN EXPRESSION AND VARIANT TRANSLOCATION IN BURKITTS-LYMPHOMA [J].
LENOIR, GM ;
PREUDHOMME, JL ;
BERNHEIM, A ;
BERGER, R .
NATURE, 1982, 298 (5873) :474-476
[8]   p53 abnormalities in B-cell prolymphocytic leukemia [J].
Lens, D ;
DeSchouwer, PJJC ;
Hamoudi, RA ;
AbdulRauf, M ;
Farahat, N ;
Matutes, E ;
Crook, T ;
Dyer, MJS ;
Catovsky, D .
BLOOD, 1997, 89 (06) :2015-2023
[9]   Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia [J].
McCune, SL ;
Gockerman, JP ;
Moore, JO ;
Decastro, CM ;
Bass, AJ ;
Chao, NJ ;
Long, GD ;
Vredenburgh, JJ ;
Gasparetto, C ;
Adams, D ;
Payne, N ;
Rizzieri, DA .
LEUKEMIA & LYMPHOMA, 2002, 43 (05) :1007-1011
[10]   Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course [J].
Put, Natalie ;
Van Roosbroeck, Katrien ;
Konings, Peter ;
Meeus, Peter ;
Brusselmans, Caroline ;
Rack, Katrina ;
Gervais, Carine ;
Florence Nguyen-Khac ;
Chapiro, Elise ;
Radford-Weiss, Isabelle ;
Struski, Stephanie ;
Dastugue, Nicole ;
Gachard, Nathalie ;
Lefebvre, Christine ;
Barin, Carole ;
Eclache, Virginie ;
Fert-Ferrer, Sandra ;
Laibe, Sophy ;
Mozziconacci, Marie-Joelle ;
Quilichini, Benoit ;
Poirel, Helene A. ;
Wlodarska, Iwona ;
Hagemeijer, Anne ;
Moreau, Yves ;
Vandenberghe, Peter ;
Michaux, Lucienne .
ANNALS OF HEMATOLOGY, 2012, 91 (06) :863-873
12